Ultragenyx Pharmaceutical Inc. earnings per share and revenue

RARE earnings per share for the last quarter are -1.39 USD whereas the estimation was -1.31 USD which accounts for -6.23% surprise. Company revenue for the same period amounts to 164.88 M USD despite the estimated figure of 151.86 M USD. Estimated earnings per share for the next quarter are -1.56 USD, and revenue is expected to reach 145.41 M USD. Also watch annual changes over time to get a bigger picture of RARE earnings per share and revenue dynamics.